-
EP3230454
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3230454
| EP3230454 - INHIBITORS OF MIR-17-92 CLUSTER FOR ANTI-TUMOR ACTIVITY IN MULTIPLE MYELOMA AND OTHER MALIGNANCIES [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.08.2018 Database last updated on 02.11.2024 | |
| Former | Request for examination was made Status updated on 15.09.2017 | ||
| Former | The international publication has been made Status updated on 16.06.2017 | Most recent event Tooltip | 17.08.2018 | Application deemed to be withdrawn | published on 19.09.2018 [2018/38] | Applicant(s) | For all designated states Tassone, Pierfrancesco Piazzetta Osservanza 2 88100 Catanzaro / IT | For all designated states Tagliaferri, Pierosandro Via Cimarosa 89 80127 Napoli / IT | For all designated states Di Martino, Maria Teresa Via Benedetto Croce 23 88100 Catanzaro / IT | [2017/42] | Inventor(s) | 01 /
see applicant ... | [2017/42] | Representative(s) | Ghirardi, Valeria, et al Cantaluppi & Partners S.r.l. Via Strobel, 8 20133 Milano / IT | [2017/42] | Application number, filing date | 15804539.3 | 04.12.2015 | [2017/42] | WO2015EP78655 | Priority number, date | IT2014RM00712 | 09.12.2014 Original published format: IT RM20140712 | [2017/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016091747 | Date: | 16.06.2016 | Language: | EN | [2016/24] | Type: | A1 Application with search report | No.: | EP3230454 | Date: | 18.10.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.06.2016 takes the place of the publication of the European patent application. | [2017/42] | Search report(s) | International search report - published on: | EP | 16.06.2016 | Classification | IPC: | C12N15/113, A61K31/7088 | [2017/42] | CPC: |
C12N15/113 (EP,US);
A61K31/198 (EP,US);
A61K31/713 (EP,US);
C12N2310/113 (EP,US);
C12N2310/315 (EP,US);
C12N2310/3231 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/42] | Title | German: | INHIBITOREN DES MIR-17-92-CLUSTERS ZUR ANTITUMORAKTIVITÄT IN MULTIPLEM MYELOM UND ANDEREN MALIGNOMEN | [2017/42] | English: | INHIBITORS OF MIR-17-92 CLUSTER FOR ANTI-TUMOR ACTIVITY IN MULTIPLE MYELOMA AND OTHER MALIGNANCIES | [2017/42] | French: | INHIBITEURS DU GROUPE MIR-17-92 DESTINÉS À UNE ACTIVITÉ DANS LE MYÉLOME MULTIPLE ET AUTRES TUMEURS MALIGNES | [2017/42] | Entry into regional phase | 07.06.2017 | National basic fee paid | 07.06.2017 | Designation fee(s) paid | 07.06.2017 | Examination fee paid | Examination procedure | 07.06.2017 | Examination requested [2017/42] | 07.06.2017 | Date on which the examining division has become responsible | 16.03.2018 | Application deemed to be withdrawn, date of legal effect [2018/38] | 24.04.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2018/38] | Fees paid | Renewal fee | 13.11.2017 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XYI]WO2008014008 (THE JOHNS HOPKINS UNIVERSITY [US]) [X] 3,6-8 * claim - * * the whole document * [Y] 14,15 [I] 1,2,4,5,10; | [XI]WO2006119365 (COLD SPRING HARBOR LABORATORY [US]; UNIVERSITY OF NORTH CAROLINA [US]) [X] 3,6,7 * claim - * * the whole document * [I] 1,2,4,5,10; | [XI]WO2011106104 (SLOAN KETTERING INST CANCER [US]; UNIV GHENT [BE]; UNIV COLUMBIA [US];) [X] 3,6,7 * claim - * * the whole document * [I] 1,2,4,5,10; | [A]WO2007095387 (DHARMACON, INC. [US]) [A] 1-11 * page 51 - page 52; table 1; sequence 31 * * the whole document *; | [Y] - CHEN LIJUAN ET AL., "miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma", CANCER LETTERS, (20111001), vol. 309, no. 1, ISSN 1872-7980, pages 62 - 70, XP002753458 [Y] 14,15 * the whole document * DOI: http://dx.doi.org/10.1016/j.canlet.2011.05.017 | [ ] - "The clinical data of 59 newly diagnosed MM patients", (20111001), URL: http://www.sciencedirect.com/science/MiamiMultiMediaURL/1-s2.0-S0304383511002837/1-s2.0-S0304383511002837-mmc1.doc/271149/html/S0304383511002837/f161dcc594411bbe3674f6f71110f54d/mmc1.doc, (20160126), XP055244905 [ ] * the whole document * | [XI] - JASON K. MOLITORIS ET AL., "Glucocorticoid-mediated repression of the oncogenic microRNA cluster miR-17~ 92 contributes to the induction of Bim and initiation of apoptosis", MOLECULAR ENDOCRINOLOGY, (20110301), vol. 25, no. 3, doi:10.1210/me.2010-0402, ISSN 0888-8809, pages 409 - 420, XP055198988 [X] 3,6,7 * the whole document * [I] 1,2,4,5,10 DOI: http://dx.doi.org/10.1210/me.2010-0402 | [XI] - B.L. MURPHY ET AL., "Silencing of the miR-17 92 cluster family inhibits medulloblastoma progression", CANCER RESEARCH, (20131201), vol. 73, no. 23, doi:10.1158/0008-5472.CAN-13-0927, ISSN 0008-5472, pages 7068 - 7078, XP055198861 [X] 3 * the whole document * [I] 1,2,4,5,7,10 DOI: http://dx.doi.org/10.1158/0008-5472.CAN-13-0927 | [A] - "Supplementary Method(s)", (20131201), URL: http://cancerres.aacrjournals.org/content/suppl/2013/10/21/0008-5472.CAN-13-0927.DC1/meth.pdf, (20150629), XP055198917 [A] 1 * the whole document * | [A] - "Supplementary Figure Legends", (20131201), URL: http://cancerres.aacrjournals.org/content/suppl/2013/10/21/0008-5472.CAN-13-0927.DC1/figleg.pdf, (20150629), XP055198918 [A] 1 * the whole document * | [A] - "Silencing of miR-17~92 in medulloblastoma 1 Supplementary Figures Figure S1", (20131201), URL: http://cancerres.aacrjournals.org/content/suppl/2013/10/21/0008-5472.CAN-13-0927.DC1/fig1-6.pdf, (20150629), XP055198919 [A] 1 * the whole document * | [A] - "Supplementary Table S1", (20131201), URL: http://cancerres.aacrjournals.org/content/suppl/2013/10/21/0008-5472.CAN-13-0927.DC1/tab1.pdf, (20150629), XP055198921 [A] 1 * the whole document * | [XI] - E. RAO ET AL., "The miRNA-17~ 92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation", LEUKEMIA, England, doi:10.1038/leu.2011.305, (20120501), pages 1064 - 1072, URL: http://www.ncbi.nlm.nih.gov/pubmed/22116552, (20150630), XP055198858 [X] 3 * the whole document * [I] 1,2,4,5,7,10 DOI: http://dx.doi.org/10.1038/leu.2011.305 | [ ] - "Supplementary Figure Legends", (20120501), URL: http://www.nature.com/leu/journal/v26/n5/extref/leu2011305x6.doc, (20150629), XP055198967 | [ ] - "Supplementary Table S1. Primers used for the 3'UTR cloning", (20120501), URL: http://www.nature.com/leu/journal/v26/n5/extref/leu2011305x7.doc, (20150629), XP055198968 | [ ] - "Supplementary Table S2", (20120501), URL: http://www.nature.com/leu/journal/v26/n5/extref/leu2011305x8.doc, (20150629), XP055198969 | [ ] - "Supplemental Table S3", (20120501), URL: http://www.nature.com/leu/journal/v26/n5/extref/leu2011305x9.doc, (20150629), XP055198970 | [ ] - "Supplemental Table S4", (20120501), URL: http://www.nature.com/leu/journal/v26/n5/extref/leu2011305x10.doc, (20150629), XP055198972 | [ ] - "Supplementary Materials and Methods", (20120501), URL: http://www.nature.com/leu/journal/v26/n5/extref/leu2011305x11.doc, (20150629), XP055198974 | [A] - D. KALUZA ET AL., "Histone Deacetylase 9 promotes angiogenesis by targeting the antiangiogenic microRNA-17-92 cluster in endothelial cells", ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY, (20130301), vol. 33, no. 3, doi:10.1161/ATVBAHA.112.300415, ISSN 1079-5642, pages 533 - 543, XP055198930 [A] 1-11 * the whole document * DOI: http://dx.doi.org/10.1161/ATVBAHA.112.300415 | [ ] - "Supplement Material Supplemental Methods", (20130301), URL: http://atvb.ahajournals.org/content/suppl/2013/01/03/ATVBAHA.112.300415.DC1/ATV201690-ATVB_ATVB-2012-300415_supp1.pdf, (20150629), XP055198926 [ ] * the whole document * | [A] - R. BOMBEN ET AL., "The miR-17~ 92 family regulates the response to Toll-like receptor 9 triggering of CLL cells with unmutated IGHV genes", LEUKEMIA, (20120701), vol. 26, no. 7, doi:10.1038/leu.2012.44, ISSN 0887-6924, pages 1584 - 1593, XP055198859 [A] 1-11 * the whole document * DOI: http://dx.doi.org/10.1038/leu.2012.44 | [ ] - "The miR-17~92 Family Regulates the Response to Toll-like Receptor 9 Triggering of CLL cells with Unmutated IGHV Genes", (20120701), URL: http://www.nature.com/leu/journal/v26/n7/extref/leu201244x1.pdf, (20150629), XP055198946 | [ ] - "Table S1 Biological features of CLL cases", (20120701), URL: http://www.nature.com/leu/journal/v26/n7/extref/leu201244x2.xls, (20150629), XP055198947 | [ ] - (20120701), URL: http://www.nature.com/leu/journal/v26/n7/extref/leu201244x3.xls, (20150629), XP055198948 | [ ] - "Table S3 Differentially expressed genes between CpG stimulated and unstimulated UM CLL Gene Symbol Systematic Name Description Gene regulation in CLL cells stimulated with CpG Position in HeatMap", (20120701), URL: http://www.nature.com/leu/journal/v26/n7/extref/leu201244x4.xls, (20150629), XP055198949 | [ ] - "Table S4 GO categories differentially represented in CpG stimulated versus unstimulated UM CLL samples", (20120701), URL: http://www.nature.com/leu/journal/v26/n7/extref/leu201244x5.xls, (20150629), XP055198950 | [ ] - "Table S5 Differentially expressed genes between CpG stimulated and unstimulated M CLL cells Gene Symbol Systematic Name Description Gene regulation in CLL cells stimulated with CpG Position in HeatMap", (20120701), URL: http://www.nature.com/leu/journal/v26/n7/extref/leu201244x6.xls, (20150629), XP055198951 | [ ] - "Table S6 GO categories differentially represented in CpG stimulated versus unstimulated M CLL samples", (20120701), URL: http://www.nature.com/leu/journal/v26/n7/extref/leu201244x7.xls, (20150629), XP055198952 | [ ] - "Table S7 Targets of miR-17~92 family detected in down-regulated genes upon CpG stimulation of UM CLL cells", (20120701), URL: http://www.nature.com/leu/journal/v26/n7/extref/leu201244x8.xls, (20150629), XP055198953 | [A] - A. ERNST ET AL., "De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures", ONCOGENE, (20100610), vol. 29, no. 23, doi:10.1038/onc.2010.83, ISSN 0950-9232, pages 3411 - 3422, XP055008967 [A] 1-11 * the whole document * DOI: http://dx.doi.org/10.1038/onc.2010.83 | [ ] - "Supplementary Figure 1", (20100610), URL: http://www.nature.com/onc/journal/v29/n23/extref/onc201083x1.pdf, (20150630), XP055199045 | [A] - DEWS MICHAEL ET AL., "Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster", NATURE GENETICS, vol. 38, no. 9, doi:10.1038/NG1855, ISSN 1061-4036, (200609), pages 1060 - 1065, (20060920), XP009113009 [A] 1-11 * the whole document * DOI: http://dx.doi.org/10.1038/ng1855 | [ ] - "Supplementary Table 1", (20060901), URL: http://www.nature.com/ng/journal/v38/n9/extref/ng1855-S1.pdf, (20150630), XP055199060 | [ ] - "Supplementary Table 2", (20060901), URL: http://www.nature.com/ng/journal/v38/n9/extref/ng1855-S2.pdf, (20150630), XP055199061 | [ ] - Gene, "Supplementary Table 3. Sequences of qRT-PCR primers and 2'-O-methyl oligoribonucleotides", (20060901), URL: http://www.nature.com/ng/journal/v38/n9/extref/ng1855-S3.pdf, (20150630), XP055199062 | [A] - E. MOGILYANSKY AND I. RIGOUTSOS, "The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease", CELL DEATH AND DIFFERENTIATION, (20131201), vol. 20, no. 12, doi:10.1038/cdd.2013.125, ISSN 1350-9047, pages 1603 - 1614, XP055199409 [A] 1-11 * the whole document * DOI: http://dx.doi.org/10.1038/cdd.2013.125 |